HIV-associated anemia in children: a systematic review from a global perspective
Authors:
- Job Cj CalisJCJob Cj Calis
- Michaël Boele van HensbroekMHMichaël Boele van Hensbroek
- Rob J de HaanRHRob J de Haan
- Peter MoonsPMPeter Moons
- Bernard J BrabinBBBernard J Brabin
- Imelda BatesIBImelda Bates
- 19 June 2008
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 22 (10) , 1099-1112
Abstract
To assess the importance of anemia in HIV-infected children in western and tropical settings. A systematic review with a descriptive component. : Four databases were searched and reference lists of pertinent articles were checked. Studies that reported data on anemia or hemoglobin levels in HIV-infected children were selected and grouped according to the location and the definition of anemia. Thirty-six studies met the inclusion criteria. Mild (hemoglobin <11 g/dl) and moderate (hemoglobin <9 g/dl) anemia were more prevalent with HIV infection (odds ratio 4.5; 95% confidence interval 2.5-8.3 and odds ratio 4.5; 95% confidence interval 2.0-10.3, respectively). Mean hemoglobin levels were lower (standardized mean difference; 0.79; 95% confidence interval 0.47-1.10). These differences were observed in both western and tropical settings. Anemia incidence ranged from 0.41 to 0.44 per person-year. There was limited data on more severe anemia (hemoglobin <7 or <5 g/dl). As anemia was frequently identified as an independent risk factor for disease progression and death, we next reviewed the limited data to formulate better strategies. Failure of erythropoiesis was the most important mechanism for anemia in HIV-infected children. Therapeutic options include highly active antiretroviral therapy and prevention or treatment of secondary infections. Erythropoietin can improve anemia in children, but it has not been evaluated in developing countries. Micronutrient supplementation may be helpful in individual children. The potential benefits or risks of iron supplementation in HIV-infected children require evaluation. Anemia is a very common complication of pediatric HIV infection, associated with a poor prognosis. With the increasing global availability of highly active antiretroviral therapy, more data on the safety and efficacy of possible interventions in children are urgently needed.Keywords
This publication has 97 references indexed in Scilit:
- Child development: risk factors for adverse outcomes in developing countriesThe Lancet, 2007
- Nutrition Rehabilitation of HIV-Infected and HIV-Negative Undernourished Children Utilizing SpirulinaAnnals of Nutrition and Metabolism, 2005
- Treatable factors associated with severe anaemia in adults admitted to medical wards in Blantyre, Malawi, an area of high HIV seroprevalenceTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- Nutritional and Clinical Status of Children Admitted to the Malnutrition Ward, Maputo Central Hospital: A Comparison of Data from 2001 and 1983Journal of Tropical Pediatrics, 2005
- Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'IvoireAIDS, 2004
- Population Pharmacokinetics and Pharmacodynamics of Zidovudine in HIV‐Infected Infants and ChildrenThe Journal of Clinical Pharmacology, 2003
- Development of a prognosis-based clinical staging system for infants infected with human immunodeficiency virusThe Journal of Pediatrics, 1996
- Recombinant erythropoietin for treatment of anaemia in HIV-infected childrenAIDS, 1996
- Zidovudine treatment increases erythrocyte adenosine deaminase activityAIDS, 1991
- Hematological abnormalities in hemophilic patients with human immunodeficiency virus infectionAmerican Journal of Hematology, 1990